| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | QKY617BBX5 |
| InChI Key | ILUPZUOBHCUBKB-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C23H21F3N2O4S |
| Molecular Weight | 478.49 |
| AlogP | 5.31 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 88.52 |
| Molecular species | ACID |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 33.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Peroxisome proliferator-activated receptor alpha agonist |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | ||
|
Enzyme
|
- | - | - | - | ||
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group C
Nuclear hormone receptor subfamily 1 group C member 1
|
4-15 | - | 170 | - | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group C
Nuclear hormone receptor subfamily 1 group C member 2
|
160-2830 | - | - | - | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group C
Nuclear hormone receptor subfamily 1 group C member 3
|
9700-9710 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lipid Metabolism Disorders | 2 | D052439 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL219586 |
| DrugBank | DB07215 |
| FDA SRS | QKY617BBX5 |
| PDB | 735 |
| PubChem | 9956726 |
| SureChEMBL | SCHEMBL3673228 |
| ZINC | ZINC000016052349 |